Abstract:Objective To evaluate the feasibility of transarterial prostate embolization for reducing the volume and its technical safety in hormone-induced dogs prostate hyperplasia.Methods Prostate hyperplasia was induced on 12 adult male dogs by administering testosterone propionate for 12 weeks.Then,the dogs were randomly assigned to transarterial prostatic embolization group (n =6) and control group (n =6).Twelve weeks after initiating the hormone treatment,6 animals in transarterial prostatic embolization group underwent prostatic arterial embolization with Embospheres 100-300 μm in diameter.Based on MRI,the volume of prostate was measured for both groups on the three time points:before injection of hormone (BI),before the procedure of prostatic arterial embolization (BP) and 12 weeks after the procedure of prostatic arterial embolization (AP).Finally,the prostates and surrounding tissues were harvested for histopathology study.A statistical software package (SPSS version 19.0) was used for analysis.Measurement data were expressed as x-± s.Samples paired t test was used to compare the prostatic volume between BP and AP.The t test was applied in the intergroup comparison.P ＜ 0.05 was considered to indicate a statistically significant difference.Results The successful rate of BPH model establishment and superselective catheterization were 100％.No serious procedure-related complication was observed.After 12 weeks of hormone administration,the mean volume of prostate was 19.5 ± 2.5 mm3 in embolization group and 19.2 ±3.8 mm3 in control group before prostatic arterial embolization,without statistical difference(t =0.14,P ＞0.05).At 12 weeks after prostatic arterial embolization,the mean volume of prostate was 6.1 ± 1.4 mm3 in embolization group and 17.8 ± 3.5 mm3 in control group with significant statistical difference (t =-7.6,P ＜ 0.05).Compared with pretreatment measurement,the mean volume of prostate decreased by 68.7％ at 12 weeks after prostatic arterial embolization with significant statistical difference (t =10.7,P ＜ 0.05).But there was no statistical difference between the two time points in control group with a 7.3％ mean decrease (t =1.4,P ＞0.05).Histopathology study revealed that embosphere particles had occluded partial arterioles of the prostate in the embolization group of dogs.Near the occluded arterioles,normal gland structure disappeared; while residual gland tissue appeared to be atrophied.In embolization group,there was no gross or microscopic change in the surrounding tissues including bladder,deferent duct and rectum.Extensive prostate glandular hyperplasia was observed in control group.Conclusions Transcatheter arterial embolization is feasible for reducing prostate volume without serious complication in hormone-induced prostate hyperplasia dogs and worthy of further investigation.

Effect of pulsed electromagnetic field therapy on prostate volume and vascularity in the treatment of benign prostatic hyperplasia: A pilot study in a canine model

[Effect of Electrovaporization on the Prostate and Its Surrounding Tissues].

Reproductive and endocrinological effects of Benign Prostatic Hyperplasia and finasteride therapy in dogs

Benign Prostatic Hyperplasia after Prostatic Arterial Embolization in a Canine Model: A 3T Multiparametric MRI and Whole-Mount Step-Section Pathology Correlated Longitudinal Study

Effects Of Low-Frequency Ultrasound Combined With Microbubbles On Benign Prostate Hyperplasia

Combined low-frequency ultrasound and microbubble contrast agent for the treatment of benign prostatic hyperplasia.

Biocompatibility and Efficacy of Prostatic Urethral Lift in Benign Prostate Hyperplasia: an in Vivo and in Vitro Study

Benign prostate hyperplasia: evaluation of treatment response with DCE MRI

Pulsed electromagnetic field therapy's effect on bladder cancer cell line HT-1376.

Dynamic contrast enhanced magnetic resonance imaging as a biological marker to noninvasively assess the effect of finasteride on prostatic suburethral microcirculation.

Safety And Feasibility Of Prostatic Tissue Ablation In Dogs By Percutaneous Irreversible Electroporation (Ire) Using A Newly-Developed High-Voltage Steep-Pulse-Therapy Device

Transarterial Prostatic Embolization: Initial Experience in Hormone-Induced Benign Prostatic Hyperplasia in Dogs

Prostatic elasticity: a new non-invasive parameter to assess bladder outlet obstruction caused by benign prostatic hyperplasia (a canine experiment).

Pharmacokinetic parameters as a potential predictor of response to pharmacotherapy in benign prostatic hyperplasia: a preclinical trial using dynamic contrast-enhanced MRI.

Efficacy and safety of electroacupuncture for benign prostatic hyperplasia: A systematic review and meta-analysis

Influence of benign prostatic hyperplasia patterns detected with MRI on the clinical outcome after prostatic artery embolization

High-Frequency Pulsed Electric Field Ablation in Beagle Model for Treatment of Prostate Cancer

Radial Extracorporeal Shock Wave Therapy as a Novel Agent for Benign Prostatic Hyperplasia Refractory to Current Medical Therapy

Prostatic Arterial Embolization for Benign Prostatic Hyperplasia in High-Risk Aged Males

A Systematic Review and Single-Arm Meta-Analysis on the Efficacy of High-Intensity, Focused Ultrasound for Benign Prostatic Hyperplasia Treatment: A Forgotten Option?

Image-guided robot-assisted prostate ablation using water jet-hydrodissection: initial study of a novel technology for benign prostatic hyperplasia